TY  - JOUR
AU  - Hochberg, Marc C
AU  - Martel-Pelletier, Johanne
AU  - Monfort, Jordi
AU  - Möller, Ingrid
AU  - Castillo, Juan Ramón
AU  - Arden, Nigel
AU  - Berenbaum, Francis
AU  - Blanco, Francisco J
AU  - Conaghan, Philip G
AU  - Doménech, Gema
AU  - Henrotin, Yves
AU  - Pap, Thomas
AU  - Richette, Pascal
AU  - Sawitzke, Allen
AU  - du Souich, Patrick
AU  - Pelletier, Jean-Pierre
AU  - MOVES Investigation Group
PY  - 2015
DO  - 10.1136/annrheumdis-2014-206792
UR  - http://hdl.handle.net/10668/10493
T2  - Annals of the rheumatic diseases
AB  - To compare the efficacy and safety of chondroitin sulfate plus glucosamine hydrochloride (CS+GH) versus celecoxib in patients with knee osteoarthritis and severe pain. Double-blind Multicentre Osteoarthritis interVEntion trial with SYSADOA (MOVES)...
LA  - en
KW  - Analgesics
KW  - NSAIDs
KW  - Osteoarthritis
KW  - Aged
KW  - Celecoxib
KW  - Chondroitin Sulfates
KW  - Cyclooxygenase 2 Inhibitors
KW  - Double-Blind Method
KW  - Drug Combinations
KW  - Edema
KW  - Female
KW  - Glucosamine
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Musculoskeletal Pain
KW  - Osteoarthritis, Knee
KW  - Pain Measurement
KW  - Quality of Life
KW  - Treatment Outcome
TI  - Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib.
TY  - research article
VL  - 75
ER  -